There wasn’t obvious inhibition of tumor growth until Day 31 during the late stages in the treatment and there were large individual differences in tumor growth inhibition rate, possibly because of high redundancy in transport which meant only part of the hENT1 protein we upregulated played a role [45]. This evidence concerns the gene SLC29A1 and neoplasm.